A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix(®) Vaccine When Given to Healthy Infants at 3 and 12 Months of Age
一项3B期开放标签研究，旨在评估四价脑膜炎球菌疫苗Nimenrix®在3个月和12个月龄健康婴儿中接种时的免疫原性和安全性。
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-01098-8
Koski, Susanna; Martinon-Torres, Federico; Rämet, Mika; Zolotas, Lefteris; Newton, Ryan; Maansson, Roger; Cutler, Mark; Peyrani, Paula; Findlow, Jamie; Balmer, Paul; Jodar, Luis; Gruber, William C; Anderson, Annaliesa S; Beeslaar, Johannes
